Hepatitis B
📧 Sign up to get email alerts when something new happens for Hepatitis B.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2019-09-06Clinical Trial Update: Safety and Immunogenicity of Hexavalent Vaccine(DTwP-HepB-IPV-Hib) in Healthy Infants [Phase 2]
Phase 2 study assessing safety and immunogenicity of a hexavalent DTwP-HepB-IPV-Hib vaccine in healthy infants; status not specified.
-
CLINICAL_TRIALS trial_result · 2019-08-28Clinical Trial Update: Add-on Peginterferon Following Nucleos(t)Ide Analogue Treatment [Phase 2]
Phase 2 trial evaluating add-on peginterferon after nucleos(t)ide analogue therapy for chronic hepatitis B has completed with posted results…
-
CLINICAL_TRIALS trial_result · 2019-08-28Clinical Trial Update: Tenofovir Alafenamide With Fine Needle Aspiration Biopsy in Chronic Hepatitis B: [Phase 4]
Phase 4 trial update investigating tenofovir alafenamide with fine-needle aspiration biopsy in chronic hepatitis B.
-
CLINICAL_TRIALS trial_result · 2019-08-14Clinical Trial Update: A Phase IV Study to Assess the Safety of EupentaTM Inj [Phase 4]
Phase IV study update assessing the safety of EupentaTM Inj; the document lists multiple conditions and an unknown status for the trial.
-
CLINICAL_TRIALS trial_result · 2019-07-31Clinical Trial Update: An Open-label Trial of 48-week Peginterferon Alfa-2a (PEGASYS) to Assess the Sustained Response of Chronic Hepatitis B Patients With HBeAg Seroconversion on Nucleot(s)Ide Analogue Therapy [Phase 4]
Open-label Phase 4 trial evaluating 48-week Peginterferon alfa-2a for sustained response in chronic hepatitis B patients with HBeAg seroconv…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2019-07-30Clinical Trial Update: Efficacy of HBV Vaccine in Consolidation of Nucleos(t)Ide Analogues Therapy [Phase 4]
Phase 4 trial update evaluating the efficacy of an HBV vaccine as consolidation therapy with nucleos(t)ide analogues in chronic hepatitis B.
-
CLINICAL_TRIALS trial_result · 2019-07-30Clinical Trial Update: Immunogenicity of Hepatitis B Vaccination in Methadone Maintenance Treatment Patients [Phase 4]
Phase 4 trial assessing immunogenicity of Hepatitis B vaccination in patients undergoing methadone maintenance treatment.
-
CLINICAL_TRIALS trial_result · 2019-07-26Clinical Trial Update: A Perspective Study of the Antiviral Efficacy and Safety of Switching to TAF Treatment in CHB Adults With Suboptimal Response (SOR) and Intolerant to Entecavir [Phase 4]
Phase 4 trial updates the antiviral efficacy and safety of switching to TAF in adults with chronic hepatitis B who have suboptimal response …
-
CLINICAL_TRIALS trial_result · 2019-07-19Clinical Trial Update: A Study to Assess the Immunogenicity and Safety of GSK Biologicals' Infanrix-IPV/Hib Vaccine Administered as a Three-dose Vaccination Course at 3, 4.5 and 6 Months of Age and a Booster Dose at 18 Months of Age in Healthy Infants in Russia [Phase 3]
Phase 3 trial assessing immunogenicity and safety of Infanrix-IPV/Hib given in a three-dose schedule with a booster in healthy infants in Ru…
-
CLINICAL_TRIALS trial_result · 2019-07-05Clinical Trial Update: A Multicenter Study to Determine the Depth and Duration of Hepatitis B Surface Antigen (HBsAg) Reduction After Single or Multiple Doses of ARC-520, in Combination With Entecavir in Patients With Chronic Hepatitis B Virus (HBV) Infection [Phase 2]
Phase 2 multicenter study assessing depth and duration of Hepatitis B surface antigen reduction after ARC-520, with or without Entecavir, in…
-
CLINICAL_TRIALS trial_result · 2019-06-27Clinical Trial Update: Long-term Persistence of Hepatitis B and Pertussis Antibody Responses in Healthy 4 to 5 Year Old Children Previously Vaccinated With Vaxelis® or INFANRIX® Hexa (V419-012) [Phase 3]
Phase 3 trial update on long-term persistence of hepatitis B and pertussis antibody responses in healthy 4–5 year-old children previously va…
-
CLINICAL_TRIALS trial_result · 2019-06-26Clinical Trial Update: Therapeutic Hepatitis B Vaccine (Mimogen-based) Joint Entecavir in Treating Chronic Hepatitis B Patients [Phase 2]
Phase 2 trial update for a Mimogen-based therapeutic Hepatitis B vaccine used with Entecavir in chronic Hepatitis B patients; study complete…
-
CLINICAL_TRIALS trial_result · 2019-06-04Clinical Trial Update: Safety and Efficacy of GS-4774 in Combination With Tenofovir Disoproxil Fumarate (TDF) for the Treatment of Participants With Chronic Hepatitis B (CHB) and Who Are Currently Not on Treatment [Phase 2]
Phase 2 trial evaluating safety and efficacy of GS-4774 in combination with tenofovir disoproxil fumarate for chronic hepatitis B; study com…
-
CLINICAL_TRIALS trial_result · 2019-05-24Clinical Trial Update: Immunogenicity and Persistence of Hepatitis B Vaccination in Methadone Maintenance Treatment Patients [Phase 4]
Phase 4 clinical trial updating immunogenicity and persistence of Hepatitis B vaccination in patients undergoing methadone maintenance treat…
-
CLINICAL_TRIALS trial_result · 2019-05-24Clinical Trial Update: Research on Optimal Immunization Strategy of Hepatitis B Vaccine in Chronic Kidney Disease Population [Phase 4]
Phase 4 clinical trial update exploring optimal immunization strategy for Hepatitis B vaccine in individuals with chronic kidney disease.
-
CLINICAL_TRIALS trial_result · 2019-05-24Clinical Trial Update: Immunogenicity and Persistence of Hepatitis B Vaccination in HIV-Infected Patients [Phase 4]
A Phase 4 clinical trial evaluating immunogenicity and persistence of Hepatitis B vaccination in HIV-infected patients.
-
CLINICAL_TRIALS trial_result · 2019-05-20Clinical Trial Update: Utilization and Efficacy of Tenofovir DF in Adolescents With Chronic Hepatitis B Virus Infection [Phase 4]
Phase 4 trial update on the use of Tenofovir DF in adolescents with chronic hepatitis B, terminated with posted results.
-
CLINICAL_TRIALS trial_result · 2019-05-08Clinical Trial Update: Combination Treatment With REP 2139-Ca and Pegasys in Patients With Chronic Hepatitis B [Phase 2]
Phase 2 trial update on combination therapy REP 2139-Ca with Pegasys for chronic hepatitis B completed with posted results.
-
CLINICAL_TRIALS trial_result · 2019-04-26Clinical Trial Update: TAF Switch in F3/4 CHB pt With Partial Response to NUC (ESTAB-AFPVR) [Phase 4]
Phase 4 clinical trial update on TAF switch in hepatitis B patients with partial response to nucleos(t)ide therapy (ESTAB-AFPVR).
-
CLINICAL_TRIALS trial_result · 2019-04-16Clinical Trial Update: A Multi-dose Study of ARC-520 in Patients With Hepatitis B 'e' Antigen (HBeAg) Negative, Chronic Hepatitis B Virus (HBV) Infection [Phase 2]
Phase 2 multi-dose study of ARC-520 for chronic hepatitis B patients who are HBeAg-negative was terminated, with results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-04-16Clinical Trial Update: A Multi-dose Study of ARC-520 in Patients With Hepatitis B 'e' Antigen (HBeAg) Positive, Chronic Hepatitis B Virus Infection [Phase 2]
A Phase 2 multi-dose trial of ARC-520 in HBeAg-positive chronic hepatitis B patients was terminated, with results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-04-16Clinical Trial Update: Extension Study of the Safety and Efficacy of Multi-dose Intravenous ARC-520 in Patients With Chronic Hepatitis B (HBV) Infection [Phase 2]
Extension phase 2 trial of ARC-520 for chronic Hepatitis B was terminated, and results have been posted.
-
CLINICAL_TRIALS trial_result · 2019-04-12Clinical Trial Update: Study of ARC-520 With or Without Other Drugs Used in the Treatment of Chronic Chronic Hepatitis B Virus (HBV) [Phase 2]
Phase 2 study of ARC-520 for chronic hepatitis B with or without other drugs was terminated; results were posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-03-21Clinical Trial Update: Hepatitis B Booster Study in Adolescence [Phase 4]
Phase 4 clinical trial evaluating a hepatitis B booster in adolescence has completed with results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-03-18Clinical Trial Update: Tenofovir Versus Tenofovir + Telbivudine for Chronic Hepatitis B [Phase 4]
Phase 4 clinical trial comparing tenofovir monotherapy to tenofovir combined with telbivudine for chronic hepatitis B; status currently unkn…